Investment & Finance
Europe Now a Growth Priority for North American Cannabis Capital
North American institutional cannabis investors now see the European medical market as a crucial driver of growth, a new survey suggests.
tilray
57stories
8 Octlast updated
More in tilray
- CBD Market
Medicare CBD Coverage Proposed, But Federal Ban Threatens Entire Industry
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to authorise insurance coverage for CBD products under certain Medicare programs, even as the same products face an existential threat from recently passed federal legislation.
- Investment & Finance
Trump Sends Cannabis Stocks Surging, Cantourage Brings in Investor Relations Help, & Mamedica Secures £4.5m
Cannabis Stocks Surge on Trump Video Global cannabis stocks have enjoyed a considerable, but likely temporary, run this week, after US President Donald Trump shared a video apparently endorsing the use of CBD for senior healthcare.
- Uncategorized
Portuguese Police Bust Criminal Gang Operating As Medical Cannabis Cultivators
Portuguese cultivators have welcomed moves by the country’s police to crack down on a criminal gang using loopholes in its medical cannabis laws to cultivate and illegally export around £15m of product.
- Uncategorized
Tilray & Flora Growth Target Stock Consolidation as Values Continue Decline, Chill Brands Raises £1m From Major Shareholder
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The international cannabis giant has announced plans to issue a ‘reverse stock split’, an increasingly common tool in the cannabis industry to artificially inflate stock prices.
- Uncategorized
Tilray’s Stock Price Drops Over 20% as Q3 Financials Miss Estimates
Tilray’s stock price has tumbled some 24% since the start of the week as its Q3 2025 financial figures failed to meet analysts’ expectations.
- Markets & Stocks
Aurora & Demecan Launch First German-Grown Products, Stenocare Exits Cultivation Facility, & More From Cantourage
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was completed.
- Markets & Stocks
Tilray Wins Tender to Supply Luxembourg, Argent Biopharma Completes Capital Raise, & More from Stenocare
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development efforts, just weeks after delisting from the London Stock Exchange.
- Markets & Stocks
Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week amid the release of its half-year results.
